title: Compartmentalisation of EGFR signalling might potentiate the optimal use of EGFR tyrosine kinase inhibitors in cancer therapeutics.
authors.forename: M V
authors.initials: MV
authors.lastname: Karamouzis
authors.forename: P A
authors.initials: PA
authors.lastname: Konstantinopoulos
authors.forename: A G
authors.initials: AG
authors.lastname: Papavassiliou
mesh_terms: D000818:Animals; D066246:ErbB Receptors / Q000502:physiology*; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology*; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D066246:ErbB Receptors